HIGGINS ARTHUR J 4

What Happened

• Arthur J. Higgins, a director of Zimmer Biomet Holdings, Inc. (ZBH), was granted 308.711 phantom stock units on 2026-03-31. The units were reported as an award/acquisition at $0.00 (derivative security).
• This was a compensation award under the company’s non-employee director deferred compensation plan rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-31; Price reported: $0.00 per unit; Form filed: 2026-04-02.
• Security: 308.711 phantom stock units (derivative). Conversion/exercise is 1-for-1 (F2).
• Settlement: Units will be paid in cash in ten annual installments starting within 60 days after the calendar year in which the director stops serving (F3).
• Additional credits: The grant includes 99.385 phantom units accrued on 2026-01-30 under the plan’s dividend reinvestment provision (F4).
• Footnote: Units were accrued under the Zimmer Biomet Deferred Compensation Plan for Non-Employee Directors (F1).
• Shares owned after transaction: not specified in the filing.

Context

• Phantom stock units are a deferred cash-based compensation vehicle, not immediate common shares — they typically pay out in cash (here, in annual installments) and do not convey voting rights.
• Such director awards are routine compensation and do not by themselves indicate the insider’s view on the company’s stock. The filing was submitted on 2026-04-02, two days after the reported grant date.